Marie-Ange Noue is a PhD chemist trained at Curie University in Paris and at the University of Houston. She started her career working as a research scientist in petrochemicals. She later found her niche upon joining EMD Serono in 2008, where she’s held a number of positions of increasing responsibility. In her current role as Senior Director, Head of US Scientific Communications, she provides strategic leadership and oversight for activities related to Medical Information, Medical Communication, Medical Training, and Medical Education for the US. Marie-Ange chairs the Board of Directors of the Canadian Medical information network, and serves as Vice President on the Executive Board of PhactMI.

Elizabeth Brown is a Senior Director and TA Lead of Oncology Medical Writing at Merck & Co, Inc. near Philadelphia, PA. She has led regulatory projects and initiatives in the pharmaceutical industry for 20+ years. First as a laboratory scientist, then as a clinical researcher, and currently as a medical writer. Elizabeth brings a project and people management focus to her role as a regulatory medical writer and department leader. With this focus, she has developed a passion for developing people, advising teams and providing strategic guidance how to deliver efficient, effective, and high-quality documents.

Elizabeth C. Froom, PharmD, is a Senior Director in the Medical Writing and Healthcare Communications team at Evidera. She has over 20 years of medical information and writing experience. In her role she provides strategic direction and oversight to a global team of medical writers who deliver medical information services including standard response documents, custom responses, Academy of Managed Care Pharmacy (AMCP) dossiers, infographics, and promotional review. Her educational background includes a BS in pharmacy and a PharmD from the University of South Carolina College of Pharmacy.

Dr. Kulkarni is Principal Attorney for the Kulkarni Law Firm which focuses on providing legal and regulatory solutions to pharmaceutical companies and their providers. He is a pharmacist & lawyer and advises clients on bringing their product to market, focusing on post IND thru commercialization and genericization.

As ever-questioning medical communication professional with an international reputation, I have been communicating science to children, grandmothers, business professionals, government agencies, and scientific experts for more than 15 years. My technical areas of expertise span across infectious disease, immunology, oncology, and vaccines and include content deliverables at all stages within a product's lifecycle.

Brooke has worked within the pharmaceutical industry for the past 9 years starting as an MSL and progressing through escalating field and home office leadership roles. Brooke has led Medical engagement strategies across 15 launches for both small and large molecules and across multiple therapeutic areas. Brooke is currently the Head of Medical Affairs Strategy and Operations for GSK

Fabiana Ebihara has over 18 years of extensive experience in the field of medical writing, with a particular focus on leadership and regulatory affairs. Throughout her career, Fabiana has held several key leadership positions at Parexel International, where she has played a pivotal role in managing partnerships with large pharmaceutical companies. She provided financial and operational oversight and led projects covering a range of therapeutic areas. Fabiana has successfully implemented process improvements, mentored teams, and contributed to business development efforts.

Richard Swank is the former head of US Field Medical and Global Field Medical Excellence at Amgen and Founder of Scientific Engagement LLC. He has spent most of his career building medical capabilities in Medical Affairs, including building and managing MSL teams, managing medical information call centers, and improving how medical teams execute and measure field medical performance. He has a PhD in Biochemistry and Molecular Biology and prior to joining industry completed an NIH Postdoctoral Fellowship and was a senior fellow in Medical Genetics at the University of Washington.

Iris Tam, PharmD, FAMCP, is Senior Vice President & Head of Medical Affairs and HEOR at COEUS Consulting with over 30 years of experience in health care, including hospital pharmacy, managed care pharmacy, and the biopharmaceutical industry. In previous industry roles, she led Medical Affairs strategies and tactics that support market access, product value, and patient access, including accountabilities for medical communications, HEOR, AMCP dossiers, compendia submissions, guideline bodies engagement, and payer communications. From 2008 to 2021, Iris served on the AMCP Format Executive Committee which oversees the AMCP Format for Formulary Submissions for dossier development, including serving as the Chair for the last 3 years.

Sarah Jarvis leads our Global Medical Affairs consulting space at ZS. Based now in San Francisco, California, Sarah has worked in the lifesciences industry for over 25 years and has focused exclusively on working with medical affairs clients for the past 15 years at ZS. ZS has worked with more than 100 companies' Medical Affairs organizations. Sarah also previously worked at Genentech in a variety of different roles on products that spanned therapy areas and phases of the lifecycle. With COVID acting as an accelerator on the medical function, ZS is partnering with clients to support the growth and change needed to meet global demands - in the field and in headquarters - through strategy, advanced analytics, and operations projects.

In her 25+ years of industry experience, Lynn has served in both individual and leadership positions within Medical Affairs at both large and start-up companies. She is currently Sr. Director, Medical Science Liaisons at BridgeBio, where she is building and leading a field medical team in the rare cardiovascular therapeutic area. Lynn is a transformative leader with proven excellence in building & developing high performing teams. Along with her leadership positions, Lynn is very active in growing/expanding the MSL profession across the industry and is a frequent invited speaker. She has also authored/ co-authored several MSL surveys highlighting and assessing the MSL role.

In Craig’s more than 30 years working at Lilly, he has successfully worked in various positions in multiple therapeutic areas including neuroscience, diabetes and osteoporosis. Craig is a founding member of the Medical Science Liaison (MSL) program at Lilly where he worked in the New York City Metropolitan area for over 13 years in this field role. Craig spent 6 years as the MSL Trainer for Lilly USA and in 2017 became part of the Office of Medical Professional Development where is he assumed the role of the Global MSL trainer. Craig has been very active in developing benchmarking survey data on MSL standards across the pharmaceutical industry. Craig received the DIA Excellence in Service award in 2021.

Jim Wilkinson, PhD is an executive leader in global and US Medical Affairs, with over 22 years in the biopharma industry. His experience includes leading Global/US Medical Information, Global Publications, Global/US Medical Communications, Global Field-Based Medical, and US Medical Science Liaison (MSL) teams. Jim has worked in multiple therapeutic areas while also launching multiple products throughout the course of his career. He has extensive working knowledge of the commercialization process, compliance, product launches, company/product acquisition and integration, legal and regulatory guidelines, operations, omnichannel communications, and promotional review. Jim received his B.S. from UW-Madison and his Ph.D. from UM-Minneapolis.